VWR (VWR) Receiving Somewhat Positive Press Coverage, Study Shows

Media headlines about VWR (NASDAQ:VWR) have been trending somewhat positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. VWR earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave media coverage about the medical research company an impact score of 46.7123961158216 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Shares of VWR (VWR) remained flat at $$33.25 on Thursday. The company had a trading volume of 2,797,900 shares, compared to its average volume of 983,321. The company has a market cap of $4,380.00 and a price-to-earnings ratio of 17.32. The company has a current ratio of 1.25, a quick ratio of 0.79 and a debt-to-equity ratio of 1.09. VWR has a 52-week low of $24.42 and a 52-week high of $37.25.

VWR (NASDAQ:VWR) last issued its earnings results on Tuesday, November 7th. The medical research company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.46 by $0.08. The company had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.16 billion. VWR had a return on equity of 11.79% and a net margin of 4.11%. The business’s revenue was up 5.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.44 EPS. research analysts anticipate that VWR will post 1.85 earnings per share for the current fiscal year.

Several research analysts have recently commented on VWR shares. Zacks Investment Research upgraded VWR from a “hold” rating to a “buy” rating and set a $37.00 target price for the company in a research report on Tuesday, September 12th. BidaskClub lowered VWR from a “sell” rating to a “strong sell” rating in a research report on Saturday, September 2nd. Finally, ValuEngine upgraded VWR from a “hold” rating to a “buy” rating in a research report on Tuesday, November 7th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $31.67.

ILLEGAL ACTIVITY WARNING: “VWR (VWR) Receiving Somewhat Positive Press Coverage, Study Shows” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://stocknewstimes.com/2017/12/07/vwr-vwr-receiving-somewhat-positive-press-coverage-study-shows.html.

About VWR

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.

Insider Buying and Selling by Quarter for VWR (NASDAQ:VWR)

Receive News & Ratings for VWR Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply